{"name":"S.LAB (SOLOWAYS)","slug":"s-lab-soloways","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"A standard antispasmodic","genericName":"A standard antispasmodic","slug":"a-standard-antispasmodic","indication":"Irritable bowel syndrome","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"GcMAF injections (100 ng)","genericName":"GcMAF injections (100 ng)","slug":"gcmaf-injections-100-ng","indication":"Advanced cancer (various solid tumors and hematologic malignancies)","status":"phase_3"}]}],"pipeline":[{"name":"A standard antispasmodic","genericName":"A standard antispasmodic","slug":"a-standard-antispasmodic","phase":"phase_1","mechanism":"Blocks acetylcholine receptors to relax smooth muscle","indications":["Irritable bowel syndrome","Spastic colon"],"catalyst":""},{"name":"GcMAF injections (100 ng)","genericName":"GcMAF injections (100 ng)","slug":"gcmaf-injections-100-ng","phase":"phase_3","mechanism":"GcMAF (Gc-protein derived macrophage activating factor) activates macrophages to enhance immune surveillance and anti-tumor activity.","indications":["Advanced cancer (various solid tumors and hematologic malignancies)","Chronic viral infections"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}